NCT05983796尚未招募不适用
Prospective Study of 18F-HER2 PET in Evaluating the Efficacy of Anti-HER2 Therapy for Urothelial Carcinoma.
First Affiliated Hospital of Zhejiang University1 个研究点 分布在 1 个国家目标入组 100 人开始时间: 2023年8月10日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 尚未招募
- 发起方
- 入组人数
- 100
- 试验地点
- 1
- 主要终点
- Evaluating the Efficacy of Anti-HER2 Therapy for Urothelial Carcinoma
研究概览
简要总结
This is a open-label, one-arm, multicenter study aimed to explore the efficacy and safety of 18F-HER2 PET in Evaluating the Efficacy of Anti-HER2 Therapy for Urothelial Carcinoma.
研究设计
- 研究类型
- Interventional
- 分配方式
- Na
- 干预模型
- Single Group
- 主要目的
- Diagnostic
- 盲法
- None
入排标准
- 年龄范围
- 30 Years 至 80 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Informed consent document must be signed.
- •Aged 30-80 years old, both genders.
- •Patients with locally advanced or advanced urothelial carcinoma
- •Patients plan to undergo anti HER2 treatment.
排除标准
- •Subjects with active malignancies other than urothelial carcinoma within 5 years should be excluded.
- •Patients with severe liver, kidney, and hematopoietic diseases
- •Patients with other mental disorders or primary emotional disorders
- •Those who are unable to understand, comply with the research protocol, or sign an informed consent form
- •PET imaging Contraindication (including pregnant women, lactating women, women of childbearing age who have a recent fertility plan, etc.)
- •Individuals who are allergic to imaging agents
- •Hypoglycemic reactions, severe pain, etc. cannot be accompanied by PET scans
结局指标
主要结局
Evaluating the Efficacy of Anti-HER2 Therapy for Urothelial Carcinoma
时间窗: up to 2 years
次要结局
未报告次要终点
研究者
研究点 (1)
Loading locations...
相似试验
终止
不适用
Clinical Utility of FES F18 PET/CT in Metastatic Breast Cancer PatientsMetastatic Breast CancerNCT05068726GE Healthcare51
进行中（未招募）
不适用
Phase III prospective clinical trial: 18F-FCH/PET evaluation in early diagnosis of disease recurrence in prostate cancer - FCH_PETEUCTR2009-011189-27-ITISTITUTI FISIOTERAPICI OSPITALIERI
已完成
2 期
18F-FSPG PET/CT in Diagnosing Early Lung Cancer in Patients With Lung NodulesCigarette SmokerCurrent SmokerFormer SmokerMultiple Pulmonary NodulesPulmonary NoduleNCT03824535Andrei Iagaru15
已完成
早期 1 期
An Exploratory, Open Label, Single Center Study of [F-18]HX4Head and Neck CancerNCT00606424Siemens Molecular Imaging10
已完成
早期 1 期
Evaluation of [18F] FMH3 and PET as a Marker of Histamine-3 Receptor Activity in Subjects With AD Compared w/ HCAlzheimer DiseaseNCT01268020Institute for Neurodegenerative Disorders5